Agile Therapeutics: Funding, Investors & Team (Sep 2026)
Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and Ethinylestradiol. The company was founded in 1997 as Levotech, Inc. and changed its name to Agile Therapeutics, Inc. in April 2001. It is based in Princeton, New Jersey.
Agile Therapeutics has raised $56.4M across 4 funding rounds on record, the most recent an undisclosed round of $4.8M announced in Feb 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Agile Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Agile Therapeutics Funding Rounds
Agile Therapeutics raised $22.7M in a Post-IPO Equity announced in Oct 2021.
5 months later, a Post-IPO Equity of $4.9M was announced in Mar 2022.
4 months later, a Post-IPO Equity of $24.0M was announced in Jul 2022.
1.6 years later, an undisclosed round of $4.8M was announced in Feb 2024.
Agile Therapeutics Founders and Leadership Team
Contact details for the Agile Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Agile Therapeutics Funding Compared to Other Biotechnology Startups
Agile Therapeutics' latest round of $4.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Agile Therapeutics in Biotechnology and Princeton
Companies Similar to Agile Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Agile Therapeutics Funding FAQs
What does Agile Therapeutics do?
Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and Ethinylestradiol. The company was founded in 1997 as Levotech, Inc. and changed its name to Agile Therapeutics, Inc. in April 2001. It is based in Princeton, New Jersey.
How much funding has Agile Therapeutics raised?
Agile Therapeutics has raised $56.4M across 4 rounds on record. The most recent is an undisclosed round of $4.8M announced in Feb 2024.
When did Agile Therapeutics last raise funding?
Agile Therapeutics' most recent funding round on record is an undisclosed round of $4.8M, announced in Feb 2024.
Who is the CEO of Agile Therapeutics?
Al Altomari is listed as CEO at Agile Therapeutics.
Where is Agile Therapeutics headquartered?
Agile Therapeutics is based in Princeton, New Jersey, United States.
How many employees does Agile Therapeutics have?
Agile Therapeutics is in the 51-100 employee band.
How does Agile Therapeutics' funding compare to other Biotechnology startups?
Agile Therapeutics' latest round of $4.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Agile Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Agile Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.